Access cutting-edge geographic atrophy treatment through this clinical trial at a research site in Portland. Study-provided care at no cost to qualified participants.
Access geographic atrophy specialists in Portland at no cost
This study follows strict safety protocols and ethical guidelines
All study-related geographic atrophy treatment provided free
This interventional study is a single-center, open label, 26-week study, designed to evaluate the safety and treatment efficacy of K8 in patients with geographic atrophy (GA) due to age-related macular degeneration (AMD). Up to 5 subjects will receive study medication. Study treatment will be administered by intravitreal injections. Number of participants has been expanded to 30. Participants will have 7 scheduled visits - Screening with baseline (injection), safety visit 2 days after injection
Sponsor: University of Kentucky
Check if you qualify for this geographic atrophy clinical trial in Portland, ME
If you're searching for geographic atrophy treatment options in Portland, ME, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Portland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced geographic atrophy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.